How do you diagnose and manage suspected Clostridioides difficile infection in a patient with recent antibiotic exposure?

Study for the Medical Council of Canada Qualifying Examination (MCCQE) I. Engage with flashcards and multiple-choice questions with detailed feedback. Prepare confidently!

Multiple Choice

How do you diagnose and manage suspected Clostridioides difficile infection in a patient with recent antibiotic exposure?

When suspecting Clostridioides difficile infection after recent antibiotic exposure, the priority is to confirm the diagnosis, stop the antibiotic driving the problem, treat with gut-acting therapy, and prevent spread. Start by testing the stool for C. difficile toxin or toxin genes (often via PCR), recognizing that testing is indicated in patients with new-onset diarrhea and not in asymptomatic individuals. If the test is positive, discontinue the inciting antibiotic if feasible to reduce ongoing disruption of the normal gut flora. Initiate targeted therapy with an oral agent such as vancomycin or fidaxomicin, with the choice guided by disease severity; oral therapy is preferred because it delivers the drug directly to the colon where the infection is active. Metronidazole is no longer first-line for most cases. Alongside treatment, implement infection control measures—glove and gown precautions, strict handwashing with soap and water (alcohol-based sanitizers are less effective against spores), and environmental cleaning with sporicidal agents—to prevent transmission. Monitor the patient’s response and reassess if symptoms persist or recur. This approach addresses diagnosis, removing the causative antibiotic, effective gut-directed therapy, and prevention of spread.

When suspecting Clostridioides difficile infection after recent antibiotic exposure, the priority is to confirm the diagnosis, stop the antibiotic driving the problem, treat with gut-acting therapy, and prevent spread. Start by testing the stool for C. difficile toxin or toxin genes (often via PCR), recognizing that testing is indicated in patients with new-onset diarrhea and not in asymptomatic individuals. If the test is positive, discontinue the inciting antibiotic if feasible to reduce ongoing disruption of the normal gut flora. Initiate targeted therapy with an oral agent such as vancomycin or fidaxomicin, with the choice guided by disease severity; oral therapy is preferred because it delivers the drug directly to the colon where the infection is active. Metronidazole is no longer first-line for most cases. Alongside treatment, implement infection control measures—glove and gown precautions, strict handwashing with soap and water (alcohol-based sanitizers are less effective against spores), and environmental cleaning with sporicidal agents—to prevent transmission. Monitor the patient’s response and reassess if symptoms persist or recur. This approach addresses diagnosis, removing the causative antibiotic, effective gut-directed therapy, and prevention of spread.

More practice questions